Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescription

• 来源期刊: 药学学报（英文版）
• 年，卷（期）: 2020,（9）
• 所属期刊栏目: Original articles
• 页码范围: 1646-1657
• 页数: 12页
• 语种: 英文

摘要

Various medicinal ingredients with different tastes are combined according to the theory of compatibility in Chinese materia medica to achieve a better efficacy,while the mechanism was not very clear.Here,the authors studied the interaction between ingredients and human transporters such as the kidney transporters OAT1 and OAT3,the liver transporters OATP1B1 and OATP1B3,and the intestine transporter OATP2B 1 to discern the compatibility mechanism of ingredients with different tastes in the Yuanhuzhitong preparation (YHP) comprising Corydalis yanhusuo (CYH) and Angelica dahurica (AD),which could relieve pain by restraining the central system.The results show that tetrahydropalmatine (TDE),the major component of CYH,could be transported by OAT3 into kidney,OATP1B1 and OATP1B3 into liver,while imperatorin (IPT) and isoimperatorin (ISP),the two key components of AD,and AD extract showed strong inhibition to OAT1 and OAT3.What's more,AD extract also exerted strongly inhibition to human transporters OATP1B 1 and OATP1B3.It was also detected that IPT,ISP,and AD extract significantly downregulated the expression of Oatplal,Oatpla4,and Oatplb2 of liver in mice.The in vivo results show that the concentration of TDE in liver and kidney significantly decreased,while the TDE concentration in blood and brain were both significantly enhanced in the presence of IPT,ISP,and AD extract.These results suggest that the ingredients in AD with pungent taste could enhance the exposure of TDE in blood and brain by inhibiting the uptake of TDE in liver and kidney.That is to say,TDE with bitter taste could "flood up" into the central nervous system to play its therapeutic effect by the cut-off of that into liver and kidney in the presence of ingredients within AD.This paper not only proves the meridian distribution of CYH in liver and kidney with the role of OAT3,OATP1B1,and OATP1B3,but also illustrates how to improve the efficacy of CYH by reasonable compatibility with AD.This study may offer a valuable clue to illustrate the mechanism of compatibility theory.